FDA Roundup: December 17, 2024

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA posted four warning letters to companies for introducing unapproved GLP-1s, including semaglutide, tirzepatide and/or retatrutide products into interstate commerce. The letters were sent to: Xcel Peptides SwisschemsSummit Research Prime PeptidesThe agency also sent a warning letter to Veronvy, which offers unapproved and misbranded oral GLP-1 products, including one that claims to be approved by FDA.Today, the FDA announced new EU requirements for importing honey and other apiculture products, effective November 29, 2024. The EU regulation requires that all establish...